$0.3113
-0.24-43.3%
Last update: Nov 11, 1:35 PM
ZYVERSA THERAPEUTICS INC by ZyVersa Therapeutics, Inc. (ZVSA) Stock Price, Quote, News & History
ZVSAOTCEM
ZyVersa gains FDA approval for emergency use of VAR 200 in a rare kidney disease case; stock jumps on high trading volume and regulatory momentum.
You can purchase shares of ZYVERSA THERAPEUTICS INC by ZyVersa Therapeutics, Inc. (OTCEM:ZVSA) through any online brokerage.
There are no as such competitors for ZYVERSA THERAPEUTICS INC by ZyVersa Therapeutics, Inc..
ZYVERSA THERAPEUTICS INC by ZyVersa Therapeutics, Inc. has a consensus price target of $240.00.
The stock price for ZYVERSA THERAPEUTICS INC by ZyVersa Therapeutics, Inc. (OTCEM: ZVSA) is $0.0001 last updated November 11, 2026 at 1:35 PM EST.
There are no upcoming dividends for ZYVERSA THERAPEUTICS INC by ZyVersa Therapeutics, Inc..
ZYVERSA THERAPEUTICS INC by ZyVersa Therapeutics, Inc. does not have any upcoming earnings scheduled.
There is no upcoming split for ZYVERSA THERAPEUTICS INC by ZyVersa Therapeutics, Inc..
ZYVERSA THERAPEUTICS INC by ZyVersa Therapeutics, Inc. is in the Health Care sector and Biotechnology industry. They are listed on the OTCEM.
ZyVersa Therapeutics Inc is a clinical-stage biopharmaceutical company leveraging proprietary technologies to develop drugs for patients with chronic renal or inflammatory diseases with high unmet medical needs. The company has two proprietary...
